Robeco Institutional Asset Management
PTCT icon

Robeco Institutional Asset Management’s PTC Therapeutics PTCT Stock Holding History

Robeco Institutional Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$484K Sell
5,938
-314
-5% -$22.7K ﹤0.01% 781
2026
Q1 		$426K Buy
6,252
+432
+7% +$30.6K ﹤0.01% 798
2025
Q4 		$442K Buy
5,820
+87
+2% +$6.32K ﹤0.01% 778
2025
Q3 		$352K Hold
5,733
– – ﹤0.01% 819
2025
Q2 		$280K Buy
+5,733
New +$272K ﹤0.01% 831

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Robeco Institutional Asset Management's PTCT Position: Q2 2026 in Review

Robeco Institutional Asset Management reduced its PTC Therapeutics (PTCT) stake by 5% in Q2 2026, selling an estimated $22.7K and leaving 5,938 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #781.

Robeco Institutional Asset Management first reported a position in PTCT in Q2 2025 and has held it in 5 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Robeco Institutional Asset Management held 5,938 shares of PTC Therapeutics worth $484K as of Q2 2026.
  • Robeco Institutional Asset Management sold 314 PTC Therapeutics shares in Q2 2026, an estimated $22.7K.
  • PTC Therapeutics made up ﹤0.01% of Robeco Institutional Asset Management's portfolio in Q2 2026, its #781 holding.
  • Robeco Institutional Asset Management first reported a position in PTC Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.